Evaluating Drug Resistance in Breast Cancer
Author Information
Author(s): R Lacavel, F Coulet, S Ricci, E Touboul, A Flahault, JG Rateau, D Cesari, JP Lefranc, JF Bernaudin
Primary Institution: Laboratoire d'Histologie et Biologie Tumorale et Université Pierre et Marie Curie - Paris 6
Hypothesis
The study aims to develop a reliable method to evaluate the expression of three drug resistance-related genes in breast cancer samples.
Conclusion
The study found a significant relationship between the expressions of the GSTp and MRP genes in breast cancer samples.
Supporting Evidence
- 74 breast cancer surgical biopsies were evaluated.
- GSTp mRNA levels were higher in diploid tumors compared to aneuploid tumors.
- Significant correlation was found between MRP and GSTp gene expressions.
Takeaway
Researchers looked at how certain genes related to drug resistance behave in breast cancer, finding that two of them are connected.
Methodology
The study used semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR) to evaluate gene expression in breast cancer biopsies.
Limitations
The study did not assess the clinical outcomes of patients based on gene expression levels.
Participant Demographics
{"age":{"under_50":23,"over_50":51},"tumor_size":{"under_30mm":57,"over_30mm":17},"nodal_status":{"negative":65,"positive":9},"histological_typing":{"ductal":63,"lobular":10,"other":1},"receptor_status":{"ER_positive":35,"ER_negative":14,"PR_positive":33,"PR_negative":16}}
Statistical Information
P-Value
p<0.007
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website